Explore All Access
Check if your research matches the topics covered in Cardiovascular Drugs and Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cardiovascular Drugs and Therapy : Impact Factor & More
eISSN: 1573-7241pISSN: 0920-3206
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cardiovascular Drugs and Therapy Key Metrics
CiteScore 
5.6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
0.93
Topics Covered on Cardiovascular Drugs and Therapy
Aspirin
Myocardial infarction
Heart disease
Atrial fibrillation
Matrix metalloproteinase
Type 2 diabetes
Anticoagulant
Left ventricular hypertrophy
Low-density lipoprotein
Atherosclerotic cardiovascular disease
Heart failure
Warfarin
Percutaneous coronary intervention
Clopidogrel
Naltrexone
Hyperoxia
Coronary heart disease
Confidence interval
Oxidative stress
Clinical trial
Cardiovascular Drugs and Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cardiovascular Drugs and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cardiovascular Drugs and Therapy
Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension.
- 9 Dec 2024
- Cardiovascular drugs and therapy
Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches.
- 6 Dec 2024
- Cardiovascular drugs and therapy
Beyond the Broken Heart: Exploring Metabolic Anti-ischemic Solutions for Takotsubo Syndrome.
- 16 Nov 2024
- Cardiovascular drugs and therapy
Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome.
- 16 Nov 2024
- Cardiovascular drugs and therapy
Enhancing Glucose Uptake as a Means to Protect the Heart During Cardiopulmonary Bypass or Ischemia-Reperfusion Injury.
- 13 Nov 2024
- Cardiovascular drugs and therapy
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
- 12 Nov 2024
- Cardiovascular drugs and therapy
Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension.
- 9 Dec 2024
- Cardiovascular drugs and therapy
Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches.
- 6 Dec 2024
- Cardiovascular drugs and therapy
Beyond the Broken Heart: Exploring Metabolic Anti-ischemic Solutions for Takotsubo Syndrome.
- 16 Nov 2024
- Cardiovascular drugs and therapy
Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome.
- 16 Nov 2024
- Cardiovascular drugs and therapy
Enhancing Glucose Uptake as a Means to Protect the Heart During Cardiopulmonary Bypass or Ischemia-Reperfusion Injury.
- 13 Nov 2024
- Cardiovascular drugs and therapy
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
- 12 Nov 2024
- Cardiovascular drugs and therapy
Compare Similar Journals with Cardiovascular Drugs and Therapy
Select Journals to Compare with Cardiovascular Drugs and Therapy
Total journals - 9
You can select up to 3 Journals at a time
European Heart Journal
Publisher: OXFORD UNIV PRESS
Circulation
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Journal of the American College of Cardiology
Publisher: ELSEVIER SCIENCE INC
International Journal of Cardiology
Publisher: ELSEVIER IRELAND LTD
Journal of the American Heart Association
Publisher: WILEY
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Clinical Medicine
Publisher: MDPI
European Journal of Preventive Cardiology
Publisher: OXFORD UNIV PRESS
Medicine
Publisher: Elsevier
0 Journals Selected to compare with
Cardiovascular Drugs and Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cardiovascular Drugs and Therapy
How long has Cardiovascular Drugs and Therapy been actively publishing? 
Cardiovascular Drugs and Therapy has been in operation since 1987 till date.
What is the publishing frequency of Cardiovascular Drugs and Therapy?
Cardiovascular Drugs and Therapy published with a Bi-monthly frequency.
How many articles did Cardiovascular Drugs and Therapy publish last year?
In 2023, Cardiovascular Drugs and Therapy publsihed 57 articles.
What is the eISSN & pISSN for Cardiovascular Drugs and Therapy?
For Cardiovascular Drugs and Therapy, eISSN is 1573-7241 and pISSN is 0920-3206.
What is Citescore for Cardiovascular Drugs and Therapy?
Citescore for Cardiovascular Drugs and Therapy is 5.6.
What is SNIP score for Cardiovascular Drugs and Therapy?
SNIP score for Cardiovascular Drugs and Therapy is 0.93.
What is the SJR for Cardiovascular Drugs and Therapy?
SJR for Cardiovascular Drugs and Therapy is Q1.
Who is the publisher of Cardiovascular Drugs and Therapy?
SPRINGER is the publisher of Cardiovascular Drugs and Therapy.
Your document is 100% secure & confidential 
